Other

Fair Value

Alnylam Pharmaceuticals Fair Value increased by 25.7% to $1.60B in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2025
Last reportedQ1 2026
Metric ID: other_debt_securities_available_for_sale_including_cash__f1a262

Historical Data

2 periods
 Q4 '25Q1 '26
Value$1.27B$1.60B
QoQ Change—+25.7%
Range$1.27B – $1.60B

Frequently Asked Questions

What is Alnylam Pharmaceuticals's fair value?
Alnylam Pharmaceuticals (ALNY) reported fair value of $1.60B in Q1 2026.